INTRODUCTION AND WELCOME — PROGRAM CHAIR
Jerry S. Wolinsky, MD (Program Chairman)

Clinical Pathobiology, Neuroprotection, Disease Modification, and Implications for Therapeutic Interventions in Multiple Sclerosis
Kenneth P. Johnson, MD

Long-Term Effectiveness of Immunomodulatory Therapy in Multiple Sclerosis: Challenges, Complications, and Regimen Adherence—A Roadmap To Optimizing Clinical Outcomes: The When, Why, and How of MS Neurotherapy
Jerry S. Wolinsky, MD

Evidence-Based Approaches to Management of Remitting-Relapsing Multiple Sclerosis (RRMS): Focus on Switching, Outcomes, and Enduring Prevention of Disability and Disease Stabilization
Andrew D. Goodman, MD

The Foundation Role of Neuroimaging in Multiple Sclerosis and Its Utility for Monitoring Disease Progression, Timing of Intervention, and Choice of Neurotherapeutic Strategies
Daniel Pelletier, MD

Challenging Cases in The Management of Multiple Sclerosis
Program Chairman and Faculty